Cristi Aitelli, MD

Publications

1. Craig DW1, O'Shaughnessy JA, Kiefer JA, Aldrich J, Sinari S, Moses TM, Wong S, Dinh J, Christoforides A, Blum JL, Aitelli CL, Osborne CR, Izatt T, Kurdoglu A, Baker A, Koeman J, Barbacioru C, Sakarya O, De La Vega FM, Siddiqui A, Hoang L, Billings PR, Salhia B, Tolcher AW, Trent JM, Mousses S, Von Hoff D, Carpten JD. Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities. Mol Cancer Ther. 2013 Jan;12(1):104-16. doi: 10.1158/1535-7163.MCT-12-0781. Epub 2012 Nov 19.
2. Aitelli C, Qin H, Becerra C, Lichliter W, and McCollum AD. Referral Patterns and Adjuvant Chemotherapy Use in Patients with Stage II Colon Cancer. Journal of Clinical Oncology 26, no. 15_suppl (May 20, 2008) 17515-17515.
3. Aitelli C, Wasson L and Page R. Pernicious anemia: presentations mimicking acute leukemia. South Med J 2003 Mar;97(3):295-7
4. Aguayo A, Kantarjian HM, Estey EH, Giles FJ, Verstovsek S, Manshouri T, Gidel C, O’Brian S, Keating MJ, Albitar M. Plasma vascular endothelial growth factor levels have a prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes. Cancer 2002 Nov;95(9): 1923-30
5. Albitar M, Manshouri T, Gidel C, Croce C, Kornblau S, Pierce S, and Kantarjian HM. Clinical significance of fragile histidine triad gene expression in adult acute lymphoblastic leukemia. Leuk Res 2001 Oct;25(10):859-64
6. Sarriera JE, Albitar M, Estrov Z, Gidel C, Aboul-Nasr R, Manshouri T, Kornblau S, Chang KS, Kantarjian HM and Estey E. Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testing. Leukemia 2001 Jan;15(1):57-61
7. Faderl S, Gidel C, Kantarjian H, Manshouri T, Keating M, and Albitar M. Loss of heterozygosity on chromosome 5 in adults with acute lymphoblastic leukemia. Leuk Res 2001 Jan;25(1):30-43
8. Aguayo A, Kantarjian HM, Manshouri T, Gidel C, Estey E, Thomas D, Koller C, Estrov Z. O’Brian S, Keating M, Freireich E, and Albitar M. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000 Sep 15;96(6):2240-2245
9. Aguayo A, O’Brian S, Keating M, Manshouri T, Gidel C, Barlogie B, Beran M, Koller C, Kantarjian HM, and Albitar M. Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia. Blood 2000 Jul 15;96(2):768-70
10. Chung CY, Kantarjian HM, Haidar M, Starostik P, Manshouri T, Gidel C, Freireich E, Keating M, and Albitar M. Deletions in the 13q14 locus in adult lymphoblastic leukemia: rate of incidence and relevance. Cancer 2000 Mar 14;88(6):1359-64
11. Aguayo A, Estey E, Kantarjian HM, Manshouri M, Gidel C, Keating M, Giles F, Estrov Z, Barlogie B, and Albitar M. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood 1999 Dec 1;94(11);3717-21